Olaparib CAS 763113-22-0 Product Guide
Table of Contents
- Product Specifications & Comparative Analysis
- Therapeutic Applications & Mechanism of Action
- Dosage & Administration Guidelines
- Clinical Efficacy Case Studies
- Industry User Testimonials
- Technical Consultation & Ordering
1. Product Specifications & Comparative Analysis
| Parameter | Olaparib CAS 763113-22-0 | Competitor A | Competitor B |
|---|---|---|---|
| Purity | ≥99.5% | ≥98.0% | ≥97.5% |
| Solubility | DMSO: 83 mg/mL | DMSO: 75 mg/mL | DMSO: 68 mg/mL |
| Storage | -20°C, 3 years | -15°C, 2 years | 4°C, 1 year |
2. Therapeutic Applications & Mechanism of Action
As a PARP (Poly ADP-ribose polymerase) inhibitor, Olaparib demonstrates exceptional performance in:
- Ovarian cancer maintenance therapy
- BRCA-mutated breast cancer treatment
- Prostate cancer with homologous recombination deficiency
- Pancreatic adenocarcinoma management
3. Dosage & Administration Guidelines
| Formulation | Recommended Dose | Frequency |
|---|---|---|
| Tablets (150mg) | 300mg | BID |
| Capsules (50mg) | 400mg | BID |
4. Clinical Efficacy Case Studies
Case 1: Advanced Ovarian Cancer Treatment
Patient Profile: 58-year-old female with BRCA1 mutation
Protocol: 300mg BID for 28-day cycles
Outcome: Progression-free survival extended by 13.6 months
Case 2: Metastatic Breast Cancer Management
Patient Profile: HER2-negative, HR-positive metastatic case
Protocol: Combination therapy with endocrine agents
Outcome: 62% reduction in tumor markers
5. Industry User Testimonials
Pharmaceutical Manufacturer A (EU-based):
“Consistent batch-to-batch purity exceeding 99.5% significantly improved our formulation stability.”
Research Hospital B (US-based):
“Superior solubility characteristics reduced our preclinical preparation time by 40% compared to alternatives.”
6. Technical Consultation & Ordering
Contact our oncology API specialists:
Email: info@vivalr.com
Tel: (86) 15866781826
Keywords: PARP inhibitor supplier, high-purity Olaparib, BRCA mutation therapy, ovarian cancer treatment API, pharmaceutical-grade CAS 763113-22-0
相关产品
Chemical Name: 1-Hexadecylamine
Synonyms 1-Aminohexadecane; Hexyldecylamine; n-Certylamine
CAS No.: 143-27-1
Molecular Formula: C16H35N
Molecular Weight: 241.46
Appearance: White Crystal
Chemical Name: Marbofloxacin
CAS No.: 115550-35-1
Molecular Formula: C17H19FN4O4
Molecular Weight: 362.36
Appearance: Red-Brown Crystal
Chemical Name: Oxirane, methyl-, polymer with oxirane, dodecyl ether
Cas No.: 68238-81-3
Molecular Fomula: C17H36O3
Molecular Weight: 288.46594
Chemical Name: Choline salicylate
CAS No.: 2016-36-6
Molecular Formula: C12H19NO4
Molecular Weight: 241.28
Appearance: Red-Brown Crystal
Chemical Name: 1,1,2,2-Tetrachloroethane
Other Name: Tetrachlorethane
CAS No.: 79-34-5
Molecular Formula: C2H2Cl4
Molecular Weight: 167.85
Appearance: Liquid
Chemical Name: D-PANTOTHENIC ACID
CAS No.: 79-83-4
Molecular Formula: C9H17NO5
Molecular Weight: 219.24
Appearance: Colorless or Light Yellow Oily Liquid
Chemical Name: N-(3-Aminopropyl)morpholine
CAS No.: 123-00-2
Molecular Formula: C7H16N2O
Molecular Weight: 144.21
Appearance: Colorless transparent liquid
Chemical Name: 4-((2-Furylmethyl)thio)-4-methylpentan-2-one
Cas No.: 64835-96-7
Molecular Fomula: C11H16O2S
Molecular Weight: 212.31
Appearance: Colorless to light yellow liquid
Chemical Name: Isoflavone
Synonyms: Soy Isoflavone; Soybean Lsoflavones; 3-Phenylchromen-4-one; 3-Phenylchromone
CAS No.: 574-12-9
Molecular Formula: C15H10O2
Molecular Weight: 222.24
Appearance: Powder
Chemical Name: DL-4-Chlorophenylglycine
Cas No.: 6212-33-5
Molecular Fomula: C8H8ClNO2
Molecular Weight: 185.61
Chemical Name: alpha-Hexylcinnamaldehyde
CAS No.: 101-86-0
Molecular Formula: C15H20O
Molecular Weight: 216.32
Appearance: Yellow Liquid
评论
目前还没有评论。